lilly 51641 has been researched along with hydroxyindoleacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barchas, JD; Collman, V; Jurik, SM; McIntire, S; Mefford, IN; Roth, KA; Tolbert, L | 1 |
| Fuller, RW; Perry, KW; Snoddy, HD | 1 |
2 other study(ies) available for lilly 51641 and hydroxyindoleacetic acid
| Article | Year |
|---|---|
Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain Chemistry; Cyclopropanes; Dopamine; Epinephrine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Inbred Strains | 1985 |
Tissue distribution, metabolism and effects of bufotenine administered to rats.
Topics: Animals; Brain; Bufotenin; Cyclopropanes; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Liver; Lung; Male; Monoamine Oxidase Inhibitors; Myocardium; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1995 |